Healthtech Startups
16,988 companies tagged Healthtech, with their investors and founders.
Surf Bio is a preclinical biopharmaceutical company developing its SnapShot technology, which uses a proprietary polymer to create ultra-high-concentration antibody and biologic formulations (600+ mg/mL, doses over 1,000 mg) for delivery via a standard autoinjector. The technology enables at-home subcutaneous self-injection of monoclonal antibodies and biologics as an alternative to in-clinic IV infusion, and is offered to pharmaceutical API manufacturers through partnerships.
2 investors
SurgeryAI builds machine-learning scheduling tools for hospital operating theatres, designed to reduce unused capacity and patient wait times. Its software, co-designed with surgeons and operational teams, serves public and private health systems including NHS trusts.
2 investors
Surgical Theater develops an XR visualization platform that helps surgeons plan and execute complex procedures by allowing them to explore patient anatomy in three-dimensional detail. The platform is used by surgical teams and patients to improve surgical outcomes and patient understanding.
2 investors
Sutro is a biotech company developing a cell-free protein synthesis platform for the design and manufacturing of complex biologics, particularly cancer therapies and antibody-drug conjugates.
2 investors
Suvida Healthcare operates primary care centers for Hispanic seniors, providing physician-led care that addresses behavioral, social, and cultural needs alongside physical health. It offers bilingual providers, dedicated care guides (Guia), caregiver support, and transportation for eligible patients.
2 investors
Suvita works to increase childhood vaccination rates in India by sending personalised SMS reminders to caregivers about their child's immunisation schedule and recruiting local community influencers as immunisation ambassadors. It operates in partnership with state governments to help parents complete their children's routine immunisation.
2 investors
Suvoda provides software solutions for managing complex clinical trials, including therapeutic areas such as oncology, central nervous system disorders, and rare disease. It serves pharmaceutical and clinical research customers, helping remove barriers to trial participation and expand access.
2 investors
Svexa develops performance intelligence software that uses AI and physiological data to generate individualized training, recovery, and wellness recommendations for athletes and organizations. Its products cover endurance and strength training plans, injury/illness risk monitoring, and API-based algorithm integration.
2 investors
Sway offers a mobile app that uses built-in phone sensors to run objective balance, cognitive, and functional assessments, including concussion baseline and sideline testing. It is used by athletic trainers, physical therapists, and other healthcare providers for sports and clinical use cases.
2 investors
SwipeRx operates a digital platform and community for pharmacy professionals across Southeast Asia, offering continuing professional education (CPD credits), industry news, and a B2B commerce tool for purchasing medicines for pharmacies. It connects a network of pharmacy professionals and retail pharmacies in the region.
2 investors
SwipeRx operates a two-sided platform connecting pharmacy professionals with independent pharmacies across Southeast Asia, enabling better pricing and faster procurement of medicines through a purchasing network.
2 investors
Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.
2 investors
Symbiome develops skin microbiome-based wellness products that restore ancestral skin health through proprietary fermentation and Amazonian botanical ingredients. The company targets consumers seeking reparative skincare solutions that address modern skin degradation through microbiome restoration.
2 investors
Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies. The company operates GMP, GLP, and ISO-certified facilities across Europe and North America to support molecules from early discovery through regulatory submission and manufacturing.
2 investors
Synaffix develops antibody-drug conjugate (ADC) technology, providing linker-payload platforms that attach small-molecule, peptide, and protein-based payloads to antibodies for use in targeted cancer therapies. The company has been integrated into Lonza's Advanced Synthesis business platform.
2 investors
Synakis develops ocular biomaterials, including its lead candidate SNK-125, through pre-clinical research and a pipeline of eye-related products. The company operates in the ophthalmic biomaterial and biotech space.
2 investors
Synapsica Healthcare develops artificial intelligence software to automate diagnostic imaging analysis and report generation for radiologists and medical facilities.
2 investors
Synapsor manufactures a continuous glucose monitoring (CGM) system designed for diabetes patients. The wearable device tracks blood glucose levels in real time via a smartphone app and includes an AI assistant for personalized glucose management support.
2 investors
2 investors
Syntra provides a real-time AI audit platform that analyzes clinical charts and claims to identify coding opportunities, ensure compliance, and automate revenue cycle processes for healthcare practices. The platform integrates with existing EHR and practice management systems to deliver pre-bill review and risk-adjusted payment audits without requiring additional staff.
2 investors
Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes. The company serves patients with genetic diseases and is based in San Francisco.
2 investors
Taconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.
2 investors
Tactile Orthopaedics develops high-fidelity surgical simulation models for orthopedic training, including knee arthroscopy simulators validated for surgical skill development. The company serves orthopedic surgeons and surgical training programs in medical education.
2 investors
TailorCare provides personalized specialty care for patients with musculoskeletal (MSK) conditions such as joint, back, and muscle pain, guiding them toward appropriate treatment plans. The company focuses on improving care journeys and health outcomes for MSK patients in the United States.
2 investors